Intel Health and Life Sciences

Sankara Eye Foundation and Singapore-based Leben Care are deploying a comprehensive retina risk assessment software-as-a-service platform in India. Netra.AI, the cloud-based artificial intelligence (AI) solution, is powered by Intel® technology and uses deep learning to identify retinal conditions in a short span of time with the accuracy level of human doctors. Netra.AI can accurately identify diabetic retinopathy (DR), greatly reducing the screening burden on vitreoretinal surgeons. “The use of AI to improve disease detection and prevention is a critical step for the healthcare industry and a giant leap for humankind. India has one of the largest diabetic populations in the world and diabetic…